Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and
Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s mission is to deliver transformative
NEW YORK, June 26, 2024 – ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW” or “the Company”) a biopharmaceutical company specializing in the advancement of novel disease-modifying
PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights New York, N.Y., April 26, 2024 – PRISM MarketView – Equities
Roche’s Alecensa Gets FDA Green Light; ImmunityBio Gains as PDUFA Date Approaches for Bladder Cancer Drug; Key Drug Trial Failures in 2024 New York, N.Y., April
PRISM Market Pulse: Market Tumbles Amid Fed’s Rate Stance; Mixed Corporate Earnings Highlight Sector Struggles New York, N.Y., April 19, 2024 – PRISM MarketView – Equities
New York, N.Y., April 18, 2024 – PRISM MarketView – More than 83,000 new cases of bladder cancer are diagnosed in the US each year, and the
Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 – PRISM MarketView
New York, N.Y., March 25, 2024 – PRISM MarketView – Drug development is an arduous, costly and time-consuming process for the teams involved behind the
New York, N.Y., March 18, 2024 – PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
